Two leading veterinary drug compounders — Wedgewood Pharmacy and Diamondback Drugs — have agreed to a merger, the companies announced July 17. Financial terms were not released.
The deal calls for the consolidated, 500-employee business to be known as Wedgewood Pharmacy and for it to be led by Wedgewood President and CEO Marcy A. Bliss. Operations will be maintained at Wedgewood’s headquarters in Swedesboro, New Jersey, and at Diamondback’s offices in Scottsdale, Arizona.
“Combining our two pharmacies will provide more capabilities and enhanced service for all of our customers,” Bliss said. “Our deep, combined expertise in compounding medications, together with best-practice prescribing tools, will enhance our customers’ experience of doing business with us. We look forward to sharing new preparations, services and tools as they are rolled out.
“During the process, our integrated pharmacist, customer care, and sales teams will allow us to stay connected with the unique needs of each veterinarian and patient we serve.”
Wedgewood took on a deep-pocketed investor in June 2016 when New Harbor Capital purchased a majority interest in the company.
Wedgewood was founded in 1980 and Diamondback in 2002.